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Ischemia–reperfusionRemote ischemic preconditioning (RIPC) of the heart is exerted by brief ischemic insults affected on a remote
organ or a remote area of the heart before a sustained cardiac ischemia. To date, little is known about the
inter-organ transfer mechanisms of cardioprotection by RIPC. Exosomes and microvesicles/microparticles are
vesicles of 30–100 nm and 100–1000 nm in diameter, respectively (collectively termed extracellular vesicles
[EVs]). Their content of proteins, mRNAs andmicroRNAs, renders EV ideal conveyors of inter-organ communica-
tion. However, whether EVs are involved in RIPC, is unknown. Therefore, here we investigated whether (1) IPC
induces release of EVs from the heart, and (2) EVs are necessary for cardioprotection by RIPC. Hearts of
male Wistar rats were isolated and perfused in Langendorff mode. A group of donor hearts was exposed to 3
× 5-5min global ischemia and reperfusion (IPC) or 30min aerobic perfusion, while coronary perfusateswere col-
lected. Coronary perfusates of these hearts were given to another set of recipient isolated hearts. A group of re-
cipient hearts received IPC efﬂuent depleted of EVs by differential ultracentrifugation. Infarct size was
determined after 30 min global ischemia and 120 min reperfusion. The presence or absence of EVs in perfusates
was conﬁrmed by dynamic light scattering, the EV marker HSP60 Western blot, and electron microscopy. IPC
markedly increased EV release from the heart as assessed by HSP60. Administration of coronary perfusate
from IPC donor hearts attenuated infarct size in non-preconditioned recipient hearts (12.9 ± 1.6% vs. 25.0 ±
2.7%), similarly to cardioprotection afforded by IPC (7.3 ± 2.7% vs. 22.1 ± 2.9%) on the donor hearts. Perfusates
of IPC hearts depleted of EVs failed to exert cardioprotection in recipient hearts (22.0 ± 2.3%). This is the ﬁrst
demonstration that EVs released from the heart after IPC are necessary for cardioprotection by RIPC, evidencing
the importance of vesicular transfer mechanisms in remote cardioprotection.
© 2014 The Authors. Published by Elsevier Ltd.Open access under CC BY license. 1. Introduction
Remote ischemic conditioning (RIPC), where a remote area of
the heart or another organ is submitted to brief cycles of ischemia–
reperfusion, protects the heart against a lethal ischemic insult with
efﬁciency comparable to that of classic in-situ ischemic protocols
[1,2]. Although effector pathways of RIPC have been well described,
it is currently unclear how cardioprotective signals are propagated
between organs [3]. Humoral and neuronal aspects have beenarch Group, Department of
University, Nagyvárad tér 4,
36 1 2104412.
(P. Ferdinandy).
. Open access under CC BY license. hypothesized, but vesicular transfer mechanisms have not been evi-
denced in inter- or intra-organ communication of RIPC signals.
Exosomes andmicrovesicles/microparticles (collectively termed ex-
tracellular vesicles, EVs) are membrane-bound structures secreted by a
wide range ofmammalian cell types via distinctmechanisms [4,5]. Since
EVs contain a high concentration of RNAs and proteins, and since EVs
can be secreted and speciﬁcally taken up by other cells, they are prime
medium for intercellular signal transfer mechanisms [5]. Thus, it is not
surprising that EVs have been shown to modulate several essential cel-
lular functions, including cell survival mechanisms [6,7]. However, to
date, it is not known whether EVs are involved in the transmission of
cardioprotective signals in ischemic conditioning maneuvers, particu-
larly, their role in the propagation of RIPC has never been studied.
Therefore, here we aimed to investigate whether the release of EVs
from the heart is induced by preconditioning stimuli; and to test if EVs
are necessary for RIPC-induced cardioprotection by assessing that RIPC
can be exerted in the presence and absence of EVs.
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This investigation conforms to the Guide for the Care and Use of Lab-
oratory Animals published by the US National Institutes of Health (NIH
publication No. 85–23, revised 1996) and was approved by the animal
ethics committee of the Semmelweis University, Budapest, Hungary.
2.1. Experimental setup, heart perfusion protocol, and assessment of
infarct size
Male Wistar rats (250–350 g) were anesthetized by 85 mg/kg keta-
mine and 10 mg/kg xylazine and heparinized. Hearts were isolated and
perfused in Langendorff mode with 37 °C Krebs–Henseleit solution for
20 min for stabilization; then hearts were randomized to the following
groups. Perfusate donor hearts either received aerobic perfusion for an
additional 30 min (CON) or were exposed to 3 × 5-5 min ischemia
and reperfusion (PRE). Perfusate recipient hearts were perfused with
collected perfusate from either CON or PRE hearts (CON PERF and PRE
PERF, respectively). Another group of hearts received perfusate of PRE
hearts which had been previously depleted of EVs (DEPL PERF). All
hearts were then exposed to a 30 min global ischemia and 2 h reperfu-
sion (Fig. 1).
Hearts thenwere cut into 6–8 slices, sliceswereweighed, and infarct
size was assessed by TTC-staining. Infarct size was expressed as a per-
centage of the total heart weight.
2.2. Isolation of EVs and EV depletion
EVs were isolated from collected coronary perfusates by ﬁltration
and differential centrifugation. Brieﬂy, perfusates were dialyzed against
0.45% saline containing 5 mM EDTA for 4 h at room temperature then
vacuum-distilled to 40 mL. Concentrated perfusates were ﬁlteredFig. 1. Experimental protocol of Langendorff-perfused rat hearts. CONthrough 800 nm ﬁlter (Merck, Darmstadt, Germany) and centrifuged
at 12,200 ×g for 20 min at 4 °C. Pellets were saved as microvesicle/
microparticle fraction. Then supernatants were ﬁltered through 200 nm
ﬁlter (Merck, Darmstadt, Germany) and centrifuged at 100,000 ×g for
90 min at 4 °C. Pellets were saved as exosome-rich pellet and the super-
natant was saved as EV-depleted perfusate. EV-depleted perfusates
were then reconstituted to their original volume with Krebs–Henseleit
solution and used in heart perfusion experiments.2.3. Characterization and assessment of quantity and size distribution
of EVs
Isolated vesicles were visualized by transmission electronmicrosco-
py. Vesicle pellets were ﬁxed with 4% formaldehyde, postﬁxed in 1%
OsO4. EVs were block-stained with 1% uranyl acetate in 50% ethanol,
then dehydrated in graded ethanol, and embedded in Taab 812 (Taab
Laboratories, Aldermaston, UK). Ultrathin sections were cut and then
analyzed with a Hitachi 7100 electron microscope.
Hydrodynamical average particle size of EVs in perfusates wasmea-
sured by Dynamic Light Scattering (DLS) apparatus Zetasizer Nano ZS
(Malvern Instruments, Malvern Hills, UK) (n = 3–4).
The presence and amount of EVs were assessed by HSP60 immuno-
blots from vesicular pellets and EV-depleted perfusates.
For a detailed Methods section please see Supplementary data
online.2.4. Statistical analysis
Values are expressed as mean ± SEM. One way analysis of variance
(ANOVA) followed by Fisher LSD post-hoc test was used to determine
differences in infarct size.: control; PRE: preconditioned; PERF: perfused; DEPL: depleted.
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3.1. Ischemic conditioning increases the amount of EVs released into
coronary perfusate
Coronary perfusates from preconditioned hearts (PRE) contained
more EVs than perfusates isolated from control (CON) hearts as evi-
denced by Western blot against HSP60, a well-accepted marker of EVs
(Fig. 2a). Electron micrographs revealed that these EVs can be classiﬁed
asmicrovesicle/microparticles as deﬁned by a diameter of N100 nmand
light vesicular structure (Fig. 2b upper panels), and exosomes of
b100 nm in diameter (Fig. 2b lower panel).
To further evidence that size of the particulate matter in coronary
perfusate conforms to the range of microvesicles and exosomes, we
assessed their size distribution by DLS in perfusates from PRE hearts.
As the representative diagram (Fig. 2c) shows, three populations of par-
ticles could be distinguished in our samples. Beside a small fraction of
particles with hypothetical diameter of approximately 10 nm, the
main particulate constituents fell into the size range of exosomes
(b100 nm) and microvesicles (100–1000 nm).
3.2. Perfusates depleted of EVs did not decrease infarct size
Isolated hearts that received 3 × 5-5 min ischemia and reperfusion
(PRE) before 30 min global ischemia demonstrated a signiﬁcantly re-
duced infarct size as compared to aerobically perfused hearts (CON).
In hearts perfused with coronary perfusates collected from PRE hearts
(PRE PERF) infarct size was signiﬁcantly lower than in hearts perfusedFig. 2. a: HSP60 immunoblots of depleted perfusates (DEPL PERF), EV pellets of preconditioned
size ranges of microvesicles and exosomes isolated from coronary perfusate of preconditioned
different vesicle populations. d: Infarct size indicated as percent of the total heart volume. Resuwith coronary perfusate from CON hearts (CON PERF). Perfusates of
PERF heartswhichhad been depleted of EVswere also given to recipient
hearts (DEPL PERF). Infarct size after 30 min ischemia and 2 h reperfu-
sion in DEPL PERF hearts did not differ signiﬁcantly from the extent of
infarction observed in CON PERF hearts (Fig. 2d).
4. Discussion
We have shown here for the ﬁrst time in the literature that the re-
lease of EVs from the heart after preconditioning stimuli is increased
and that EVs are responsible for the transmission of remote condition-
ing signals for cardioprotection.
Previously several humoral and neuronal transmitter mechanisms
have been hypothesized to play a role in the propagation of remote
ischemic conditioning, however, to date none of them is generally
accepted. Dickson et al. have proposed ﬁrst the involvement of hu-
moral transmission pathways showing that transfusion of blood
from preconditioned rabbits confers cardioprotection in a naïve non-
preconditioned animal against ischemia/reperfusion injury [8]. Later,
Breivik et al. showed that the soluble factor is likely to be hydrophobic
[9]. The role of neuronal pathways has also been studied, but results
are also still controversial [10,11].
Herewe evidence a novel, vesicularmechanism for the transmission
of cardioprotective signals from a preconditioned heart to another heart
subjected to coronary occlusion and reperfusion, which might explain
how the suspected humoral and/or released neuronal factors of remote
conditioning are transmitted. Ischemia-induced release of EVs from cul-
tured cardiomyocytes was reported by Malik et al. [12] recently, which(PRE) and control perfusates (CON). b: Representative electron micrographs of EVs in the
hearts. Scale bar represents 400 nm. c: DLS analysis of perfusates showing distribution of
lts are expressed as mean ± SEM; n = 5–8. *p b 0.05 vs. CON, #p b 0.05 vs. CON PERF.
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hearts increases after brief ischemic episodes. Elsewhere, exosomes de-
rived from mesenchymal stem cell cultures have been shown to exert
cardioprotection in mice [13], and microvesicles isolated from cell
culture medium of GATA-4-overexpressing bone marrow stem cells
protected neonatal cardiomyocytes from ischemic injuries [14]. Since
in the latter two reports EVs from untreated cells induced pro-survival
signals, based on our current ﬁndings, we cannot exclude the possibility
that EVs released from the heart under basal conditions might be also
cardioprotective, would their amount be as high as after precondition-
ing stimuli. Seemingly controversial to our ﬁndings, microvesicles
derived from blood of animals underwent hind limb ischemia/reperfu-
sion failed to decrease infarct size in rats [15], which might suggest
that exosomes rather than microvesicles are responsible for the propa-
gation of cardioprotective signals. Nonetheless, despite our present
ﬁndings clearly show that an increased release of EVs is indispensable
for RIPC-induced cardioprotection ex-vivo, further experiments are
warranted to investigate this phenomenon using a clinically relevant
in-vivo model for remote conditioning by hindlimb ischemia.
In summary, this is the ﬁrst demonstration that EVs are the carrier
mechanism of the cardioprotective effect of RIPC of the heart, although,
furthermolecular and in-vivo experimentation iswarranted to decipher
the nature of actual effector factors carried by these vesicles.
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